Guardian Partners’s 10x Genomics TXG Stock Holding History

Guardian Partners’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.63M	Buy	+18,000	New	+$1.05M	0.14%	100

Other funds holding TXG

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Convergence Investment Partners Palm Beach Gardens, Florida $1.35B AUM 71.9% 1-Year Est. Return

Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return

MIC

Maxi Investments CY Limassol, Cyprus $545M AUM 21.2% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

Guardian Partners's TXG Position: Q3 2026 in Review

Guardian Partners opened a new position in 10x Genomics (TXG) in Q3 2026: 18,000 shares worth $1.63M. The stake represents 0.14% of the portfolio and ranks #100 among its holdings.

126 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

Guardian Partners held 18,000 shares of 10x Genomics worth $1.63M as of Q3 2026.
10x Genomics was a new Guardian Partners position in Q3 2026.
10x Genomics made up 0.14% of Guardian Partners's portfolio in Q3 2026, its #100 holding.
126 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.